1. Home
  2. CYTK vs LBRDK Comparison

CYTK vs LBRDK Comparison

Compare CYTK & LBRDK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$64.98

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Logo Liberty Broadband Corporation Class C

LBRDK

Liberty Broadband Corporation Class C

HOLD

Current Price

$50.95

Market Cap

6.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
LBRDK
Founded
1997
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Cable & Other Pay Television Services
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
6.4B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
CYTK
LBRDK
Price
$64.98
$50.95
Analyst Decision
Strong Buy
Analyst Count
18
0
Target Price
$88.94
N/A
AVG Volume (30 Days)
1.8M
777.5K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,368,000.00
N/A
Revenue This Year
$6.88
N/A
Revenue Next Year
$308.26
$109.28
P/E Ratio
N/A
$10.10
Revenue Growth
N/A
N/A
52 Week Low
$29.31
$42.10
52 Week High
$70.98
$104.00

Technical Indicators

Market Signals
Indicator
CYTK
LBRDK
Relative Strength Index (RSI) 54.07 48.91
Support Level $59.12 $48.17
Resistance Level $67.94 $55.26
Average True Range (ATR) 2.25 1.83
MACD 0.26 0.15
Stochastic Oscillator 61.73 56.77

Price Performance

Historical Comparison
CYTK
LBRDK

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About LBRDK Liberty Broadband Corporation Class C

Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.

Share on Social Networks: